Literature DB >> 7550385

Localized renal-cell carcinoma: detection of abnormal cells in peritumoral tissue. A cytophotometry and immunocytochemistry study.

P Anton1, H J Tanke, E P Allehoff, M A Kuczyk, C G Stief, U Jonas.   

Abstract

To spare organ function, partial resection of early diagnosed renal-cell carcinoma (RCC) is applied for well-localized and small-volume RCC with increasing frequency, although recurrence of the tumor in the same kidney is occasionally observed. The aim of the present study was to establish objective prognostic parameters that would allow the selection of tumors suitable for an organsaving procedure. Of the 160 patients undergoing a radical nephrectomy, 67 were included in this study. In 7/45 patients with lymph-node dissection (15.6%), clinical staging revealed a false-negative lymph-node status. By means of conventional histopathology, multifocality could be demonstrated in 2/67 patients (3%); in 1/67 patients (1.5%), the ipsilateral adrenal gland was unexpectantly tumor-involved. Both tumor tissue and normal peritumoral tissue were examined for the presence of premalignant and tumor cells on the basis of DNA ploidy and of the expression of the tumor-associated G250 antigen, which is specifically expressed at the surface of renal cancer cells. In 40/67 (59.1%) peritumoral tissue specimens, cells with an abnormal DNA content could be observed using automated image analysis. In 12/67 cases (18%), cells obtained from peritumoral tissue also showed an aneuploid DNA histogram; 4/67 (6%) had a tumor-correlated DNA ploidy. Additionally, 38/67 (56.9%) of these tissues, histopathologically classified as normal, contained cells expressing the G250 antigen. These observations were independent of the stage or histological grade of the tumor. These data indicate that classic pathological parameters for tumor staging are insufficient for the detection of multifocality, occurring in more than 15% of cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550385     DOI: 10.1007/bf00184869

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  14 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney.

Authors:  E Oosterwijk; D J Ruiter; P J Hoedemaeker; E K Pauwels; U Jonas; J Zwartendijk; S O Warnaar
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

Review 3.  The natural history and clinical features of renal carcinoma.

Authors:  A W Ritchie; J B deKernion
Journal:  Semin Nephrol       Date:  1987-06       Impact factor: 5.299

4.  Detection of suspicious cells and rejection of artefacts in cervical cytology using the Leyden Television Analysis System.

Authors:  I Al; J S Ploem
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

5.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation.

Authors:  T H Hostetter; J L Olson; H G Rennke; M A Venkatachalam; B M Brenner
Journal:  Am J Physiol       Date:  1981-07

6.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

7.  Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients.

Authors:  A C Novick; S Streem; J E Montie; J E Pontes; S Siegel; D K Montague; M Goormastic
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

8.  Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.

Authors:  H Holthöfer; A Miettinen; R Paasivuo; V P Lehto; E Linder; O Alfthan; I Virtanen
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

9.  Acriflavine-Feulgen stilbene staining: a procedure for automated cervical cytology with a television based system (LEYTAS).

Authors:  H J Tanke; E M van Ingen; J S Ploem
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

10.  Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma.

Authors:  E Oosterwijk; D J Ruiter; J C Wakka; J W Huiskens-van der Meij; U Jonas; G J Fleuren; J Zwartendijk; P Hoedemaeker; S O Warnaar
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

View more
  2 in total

1.  Immune and genetic therapies for advanced renal cell carcinoma.

Authors:  A Zisman; A J Pantuck; A Belldegrun
Journal:  Rev Urol       Date:  2000

Review 2.  Molecular-based therapies for renal cell carcinoma.

Authors:  A Zisman; A J Pantuck; A S Belldegrun
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 3.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.